Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Lymphoma, also known as malignant lymphoma, is a general term for a group of malignant tumors originating from the lymphopoietic system. It is one of the most common tumors in China. In 2020, there were 544,352 new cases of non-Hodgkin lymphoma (NHL) worldwide, ranking 13th among all new cases of malignancies.

Abbott announced today that it has received CE marking for its Alinity m molecular diagnostics system and assays, which are now available in countries that recognize the designation. The firm said that its molecular system will help clinici

A recentstudyconcluded that a first-of-its-kind magnetic surgical system allows a safe, reproducible, incision-less technique for port-less intraabdominal mobilization. The Magnetic Surgical System, developed by Levita Magnetics, is so unlik

Medical technology has made inroads in collecting data about health status that were considered impossible just a few short years ago. Automatic recording of data from things such as heart rate to glucose levels can be determined, stored, an

A report from the Landscape Analysis Sub-Group of the Medical Device Innovation Consortium (MDIC),Somatic Variant Reference Samples for NGS, Landscape of Available Reference Samples, compiles all the currently available somatic reference sam

FDA has reported a total of10 medical device recallsso far this year, of which seven were reported in February. Seven recalls in a single month is a lot, but not unheard of. Last year there were a total of 32 medical device recalls, accordin

CareDx said it has filed a patent infringement suit against Natera in the U.S. District Court for Delaware. The Brisbane, CA-based company said it is asserting U.S. Patent Nos. 9,845,497 and 8,703,652, were exclusively licensed to itfrom Sta

Guardant Health is expanding its early cancer detection efforts through a new acquisition. The Redwood City, CA-based firm is set to pick up Bellwether Bio, a private company focused on improving oncology patient care through pioneering rese

Bacillusbacteria detection devices were previously unclassified, known as preamendment devices, since they were in commercial distribution prior to May 28, 1976, when the Medical Device Amendments to the Federal Food, Drug, and Cosmetic Act

PredictImmune announced recently that it has entered a commercial agreement with Addenbrookes Hospital part of Cambridge University Hospitals National Health Service Foundation Trust to provide the companys PredictSure IBD prognostic assay

A new study by Veracyte and collaborators demonstrates that the companys Envisia genomic test can improve the diagnosis of patients being evaluated for interstitial lung disease. The study, published this week in Lancet Respiratory Medicine